Chitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown properties

Eukaryotic Cell

Volumn 11, Issue 9, 2012, Pages 1086-1094

  Ramos, Caroline L ^a   Fonseca, Fernanda L ^a   Rodrigues, Jessica ^a   Guimarães, Allan J ^a   Cinelli, Leonardo P ^a   Miranda, Kildare ^a   Nimrichter, Leonardo ^a   Casadevall, Arturo ^b   Travassos, Luiz R ^c   Rodriguesa, Marcio L ^a,d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHITIN; CYTOKINE; DRUG DERIVATIVE; FUNGUS ANTIGEN; GLUCURONOXYLOMANNAN; POLYSACCHARIDE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CHEMISTRY; CRYPTOCOCCUS NEOFORMANS; FEMALE; IMMUNOLOGY; MACROPHAGE; METABOLISM; MOUSE;

ANIMALS; ANTIGENS, FUNGAL; CHITIN; CRYPTOCOCCUS NEOFORMANS; CYTOKINES; FEMALE; MACROPHAGES; MICE; MICE, INBRED BALB C; POLYSACCHARIDES;

FILOBASIDIELLA NEOFORMANS; MUS;

EID: 84865556124     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00001-12     Document Type: Article

References (46)

1. Baker LG, Specht CA, Donlin MJ, Lodge JK. 2007. Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryot. Cell 6:855-867.
2. Banks IR, et al. 2005. A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans. Eukaryot. Cell 4:1902-1912.
3. Barbosa FM, et al. 2006. Glucuronoxylomannan-mediated interaction of Cryptococcus neoformans with human alveolar cells results in fungal internalization and host cell damage. Microbes Infect. 8:493-502.
4. Bicanic T, Harrison TS. 2004. Cryptococcal meningitis. Br. Med. Bull. 72:99-118.
5. Camci-Unal G, Pohl NLB. 2009. Quantitative determination of heavy metal contaminant complexation by the carbohydrate polymer chitin. J. Chem. Eng. Data 55:1117-1121.
6. Casadevall A, et al. 1998. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob. Agents Chemother. 42:1437-1446.
7. Casadevall A, Mukherjee J, Scharff MD. 1992. Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J. Immunol. Methods 154: 27-35.
8. Casadevall A, Pirofski LA. 2006. Polysaccharide-containing conjugate vaccines for fungal diseases. Trends Mol. Med. 12:6-9.
9. Cherniak R, Morris LC, Anderson BC, Meyer SA. 1991. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans. Infect. Immun. 59:59-64.
10. Cherniak R, Reiss E, Slodki ME, Plattner RD, Blumer SO. 1980. Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A. Mol. Immunol. 17:1025-1032.
11. Chiapello LS, et al. 2004. Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan. Immunology 113:392-400.
12. Cleare W, Casadevall A. 1999. Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release. Med. Mycol. 37:235-243.
13. Cordero RJ, Frases S, Guimaraes AJ, Rivera J, Casadevall A. 2011. Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity. Mol. Microbiol. 79:1101-1117.
14. Cordero RJ, et al. 2011. Chronological aging is associated with biophysical and chemical changes in the capsule of Cryptococcus neoformans. Infect. Immun. 79:4990-5000.
15. Da Silva CA, et al. 2009. Chitin is a size-dependent regulator of macrophage TNF and IL-10 production. J. Immunol. 182:3573-3582.
16. Da Silva CA, Hartl D, Liu W, Lee CG, Elias JA. 2008. TLR-2 and IL-17A in chitin-induced macrophage activation and acute inflammation. J. Immunol. 181:4279-4286.
17. De Jesus M, Nicola AM, Rodrigues ML, Janbon G, Casadevall A. 2009. Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan. Eukaryot. Cell 8:96-103.
18. Dische Z. 1947. A specific color reaction for glucuronic acid. J. Biol. Chem. 171:725-730.
19. Dubois M, Gilles K, Hamilton JK, Rebers PA, Smith F. 1951. A colorimetric method for the determination of sugars. Nature 168:167.
20. Fonseca FL, et al. 2009. Structural and functional properties of the Trichosporon asahii glucuronoxylomannan. Fungal Genet. Biol. 46:496-505.
21. Fonseca FL, et al. 2009. Role for chitin and chitooligomers in the capsular architecture of Cryptococcus neoformans. Eukaryot. Cell 8:1543-1553.
22. Fonseca FL, et al. 2010. Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter. Infect. Immun. 78:3861-3870.
23. Frases S, Nimrichter L, Viana NB, Nakouzi A, Casadevall A. 2008. Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences. Eukaryot. Cell 7:319-327.
24. Frases S, et al. 2009. Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules. Proc. Natl. Acad. Sci. U. S. A. 106:1228-1233.
25. Gilbert NM, et al. 2010. KRE genes are required for beta-1,6-glucan synthesis, maintenance of capsule architecture and cell wall protein anchoring in Cryptococcus neoformans. Mol. Microbiol. 76:517-534.
26. Goldman DL, et al. 2012. Increased chitinase expression and fungalspecific antibodies in the bronchoalveolar lavage fluid of asthmatic children. Clin. Exp. Allergy 42:523-530.
27. Goldman DL, Vicencio AG. 2012. The chitin connection. mBio 3:e00056-12. doi:10.1128/mBio.00056-12.
28. Jesus MD, et al. 2010. Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans. Virulence 1:500-508.
29. Kozel TR, et al. 2003. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. Infect. Immun. 71:2868-2875.
30. Martinez LR, et al. 2010. The use of chitosan to damage Cryptococcus neoformans biofilms. Biomaterials 31:669-679.
31. McClelland EE, Bernhardt P, Casadevall A. 2005. Coping with multiple virulence factors: which is most important? PLoS Pathog. 1:e40.
32. Monari C, et al. 2009. A microbial polysaccharide reduces the severity of rheumatoid arthritis by influencing Th17 differentiation and proinflammatory cytokines production. J. Immunol. 183:191-200.
33. Monari C, Bistoni F, Vecchiarelli A. 2006. Glucuronoxylomannan exhibits potent immunosuppressive properties. FEMS Yeast Res. 6:537-542.
34. Nicola AM, Casadevall A. 2012. In vitro measurement of phagocytosis and killing of Cryptococcus neoformans by macrophages. Methods Mol. Biol. 844:189-197.
35. Nimrichter L, et al. 2007. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations. Eukaryot. Cell 6:1400-1410.
36. Oliveira DL, et al. 2010. Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions. Infect. Immun. 78:1601-1609.
37. Park BJ, et al. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23:525-530.
38. Perfect JR, Casadevall A. 2002. Cryptococcosis. Infect. Dis. Clin. North Am. 16:837-874.
39. Reese AJ, Doering TL. 2003. Cell wall alpha-1,3-glucan is required to anchor the Cryptococcus neoformans capsule. Mol. Microbiol. 50:1401-1409.
40. Reese AJ, et al. 2007. Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence. Mol. Microbiol. 63: 1385-1398.
41. Rodrigues ML, Alvarez M, Fonseca FL, Casadevall A. 2008. Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan. Eukaryot. Cell 7:602-609.
42. Rodrigues ML, Fonseca FL, Frases S, Casadevall A, Nimrichter L. 2009. The still obscure attributes of cryptococcal glucuronoxylomannan. Med. Mycol. 47:783-788.
43. Taylor RL, Conrad HE. 1972. Stoichiometric depolymerization of polyuronides and glycosaminoglycuronans to monosaccharides following reduction of their carbodiimide-activated carboxyl groups. Biochemistry 11:1383-1388.
44. Tsirilakis K, et al. 2012. Methylxanthine inhibit fungal chitinases and exhibit antifungal activity. Mycopathologia 173:83-91.
45. Vicencio AG, et al. 2008. Pulmonary cryptococcosis induces chitinase in the rat. Respir. Res. 9:40.
46. Zaragoza O, et al. 2009. The capsule of the fungal pathogen Cryptococcus neoformans. Adv. Appl. Microbiol. 68:133-216.